About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Eurasian Hematology-Oncology Group
http://www.ehog.net/
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
8th Eurasian Hematology Oncology Summit
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Palliative & Supportive Care
COVID-19
Basic Science
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
7th Eurasian Hematology Oncology Summit
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Xth Eurasian Hematology-Oncology Congress
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Events
Gastrointestinal
17:19
Xth Eurasian Hematology-Oncology Congress
New (Neo)Adjuvant Standards of Care in Gastro-Esophageal Cancer: FLOT is the New Gold Standard in Perioperative Chemo, Adjuvant Chemo+Chemoradiotherapy is Better Than Chemo Alone
FEATURING
Mehmet Artac
358 views
December 4, 2019
2
06:28
Xth Eurasian Hematology-Oncology Congress
Current Chemo Standard of Care in Biliary Tract Cancer: Cisplatin+Gemcitabine as 1st Line in Advanced Disease / mFOLFOX+APC as 2nd Line
FEATURING
Fatih Kose
221 views
December 4, 2019
1
11:12
Xth Eurasian Hematology-Oncology Congress
Current Immunotherapy and Targeted Therapy Standard of Care in Biliary Tract Cancer: Dabrafenib-Trametinib for BRAF+, Infigratinib for FGFR+, Ivsidenib for IDH-1, and Pembro for MSI-H Tumors
FEATURING
Fatih Kose
76 views
December 4, 2019
17:21
Xth Eurasian Hematology-Oncology Congress
Has Sorafenib Still Been the Real Winner Against New Generation TKIs and Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma?
FEATURING
Sahin Lacin
318 views
December 4, 2019
2
21:17
Xth Eurasian Hematology-Oncology Congress
Systemic Therapy Options for Metastatic Well-Differentiated Gastrointestinal Neuroendocrine (Carcinoid) Tumors
FEATURING
Alexander Kouzminov
173 views
December 4, 2019
18:59
Xth Eurasian Hematology-Oncology Congress
Is Tumor Sidedness, Biomarkers or Molecular Subtype Classification More Predictive for the Treatment of Unresectable Metastatic Colon Cancer?
FEATURING
Gokhan Demir
19 views
December 9, 2019